Legal status · Australia
Is Zinc-L-carnosine legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Zinc-L-carnosine can be sold in Australia as a supplement or cosmetic ingredient, classified as "Available as a supplement / complementary medicine". That is not drug approval: TGA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Zinc-L-carnosine in Australia at a glance
| Classification | Available as a supplement / complementary medicine |
|---|---|
| Note | Available as a complementary medicine. |
| TGA approval status | Not a TGA drug approval; sold as a supplement or cosmetic |
| Human studies cited | 1 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Zinc-L-carnosine profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
Zinc-L-carnosine can be sold in Australia as a supplement, food or cosmetic ingredient under the classification above, without drug approval.
- 02
Supplement status means TGA has not evaluated any health claim; manufacturers are responsible for safety and labeling, and quality varies by product.
- 03
Injectable or "research use only" versions are not supplements. That label does not make human use lawful, and injectables fall under medicines rules.
What Zinc-L-carnosine is
A zinc and dipeptide chelate approved as a gastric drug in Japan, with a randomised phase 3 showing it prevented radiotherapy-induced swallowing difficulty in breast cancer patients.
Zinc-L-carnosine sits in an unusual regulatory position. It is an approved prescription drug for gastric ulcer in Japan, where it has been used since 1994, and it is sold as a dietary supplement in the United States.
Mechanism: A one-to-one chelate of zinc and L-carnosine. The chelate adheres preferentially to ulcerated and inflamed mucosal surfaces, where it dissociates and releases zinc locally at higher concentration than systemic zinc dosing would achieve.
Regulatory history: Not an FDA-approved drug. Sold as a dietary supplement in the United States. Approved as a prescription gastric medicine in Japan, where it has been marketed since 1994.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Zinc-L-carnosine at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Zinc-L-carnosine in other countries
Frequently asked questions
Is Zinc-L-carnosine legal in Australia?
Zinc-L-carnosine can be sold in Australia as a supplement or cosmetic ingredient, classified as "Available as a supplement / complementary medicine". That is not drug approval: TGA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Available as a complementary medicine.
Can I buy Zinc-L-carnosine in Australia?
Yes, in supplement or cosmetic form. In Australia Zinc-L-carnosine is classified as "Available as a supplement / complementary medicine", so oral, topical or cosmetic products can be sold under supplement rules. Injectable versions and products labeled "research use only" are not supplements and are not approved for human use. Note: Available as a complementary medicine.
Is Zinc-L-carnosine TGA approved?
No. In Australia Zinc-L-carnosine is classified as "Available as a supplement / complementary medicine", which is not a TGA marketing approval. For comparison, the US FDA status is: Not an FDA-approved drug. Sold as a dietary supplement in the United States. Approved as a prescription gastric medicine in Japan, where it has been marketed since 1994.. On the evidence, 1 human study is cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Zinc-L-carnosine live on its compound profile.
Zinc-L-carnosine profileThis page is general information about the regulatory status of Zinc-L-carnosine in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.